233 related articles for article (PubMed ID: 16407417)
1. 130-kDa smooth muscle myosin light chain kinase is transcribed from a CArG-dependent, internal promoter within the mouse mylk gene.
Yin F; Hoggatt AM; Zhou J; Herring BP
Am J Physiol Cell Physiol; 2006 Jun; 290(6):C1599-609. PubMed ID: 16407417
[TBL] [Abstract][Full Text] [Related]
2. Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1.
Zhou J; Hu G; Herring BP
Mol Cell Biol; 2005 Nov; 25(22):9874-85. PubMed ID: 16260603
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 130-kDa smooth muscle myosin light chain kinase expression by an intronic CArG element.
Chen M; Zhang W; Lu X; Hoggatt AM; Gunst SJ; Kassab GS; Tune JD; Herring BP
J Biol Chem; 2013 Nov; 288(48):34647-57. PubMed ID: 24151072
[TBL] [Abstract][Full Text] [Related]
4. GATA-6 can act as a positive or negative regulator of smooth muscle-specific gene expression.
Yin F; Herring BP
J Biol Chem; 2005 Feb; 280(6):4745-52. PubMed ID: 15550397
[TBL] [Abstract][Full Text] [Related]
5. Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins.
Rensen SS; Niessen PM; Long X; Doevendans PA; Miano JM; van Eys GJ
Cardiovasc Res; 2006 Apr; 70(1):136-45. PubMed ID: 16451796
[TBL] [Abstract][Full Text] [Related]
6. Increased myosin light chain kinase expression in hypertension: Regulation by serum response factor via an insertion mutation in the promoter.
Han YJ; Hu WY; Chernaya O; Antic N; Gu L; Gupta M; Piano M; de Lanerolle P
Mol Biol Cell; 2006 Sep; 17(9):4039-50. PubMed ID: 16822834
[TBL] [Abstract][Full Text] [Related]
7. An intronic MYLK variant associated with inflammatory lung disease regulates promoter activity of the smooth muscle myosin light chain kinase isoform.
Han YJ; Ma SF; Wade MS; Flores C; Garcia JG
J Mol Med (Berl); 2012 Mar; 90(3):299-308. PubMed ID: 22015949
[TBL] [Abstract][Full Text] [Related]
8. Autoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling.
Basu S; Proweller A
J Biol Chem; 2016 Feb; 291(6):2988-99. PubMed ID: 26703474
[TBL] [Abstract][Full Text] [Related]
9. Smooth muscle expression of lipoma preferred partner is mediated by an alternative intronic promoter that is regulated by serum response factor/myocardin.
Petit MM; Lindskog H; Larsson E; Wasteson P; Athley E; Breuer S; Angstenberger M; Hertfelder D; Mattsson E; Nordheim A; Nelander S; Lindahl P
Circ Res; 2008 Jul; 103(1):61-9. PubMed ID: 18511849
[TBL] [Abstract][Full Text] [Related]
10. Telokin expression in A10 smooth muscle cells requires serum response factor.
Herring BP; Smith AF
Am J Physiol; 1997 Apr; 272(4 Pt 1):C1394-404. PubMed ID: 9142867
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms responsible for the promoter-specific effects of myocardin.
Zhou J; Herring BP
J Biol Chem; 2005 Mar; 280(11):10861-9. PubMed ID: 15657056
[TBL] [Abstract][Full Text] [Related]
12. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box.
Doi H; Iso T; Yamazaki M; Akiyama H; Kanai H; Sato H; Kawai-Kowase K; Tanaka T; Maeno T; Okamoto E; Arai M; Kedes L; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2328-34. PubMed ID: 16151017
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor Foxf1 binds to serum response factor and myocardin to regulate gene transcription in visceral smooth muscle cells.
Hoggatt AM; Kim JR; Ustiyan V; Ren X; Kalin TV; Kalinichenko VV; Herring BP
J Biol Chem; 2013 Oct; 288(40):28477-87. PubMed ID: 23946491
[TBL] [Abstract][Full Text] [Related]
14. The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin.
Long X; Tharp DL; Georger MA; Slivano OJ; Lee MY; Wamhoff BR; Bowles DK; Miano JM
J Biol Chem; 2009 Nov; 284(48):33671-82. PubMed ID: 19801679
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide regulates smooth-muscle-specific myosin heavy chain gene expression at the transcriptional level-possible role of SRF and YY1 through CArG element.
Itoh S; Katoh Y; Konishi H; Takaya N; Kimura T; Periasamy M; Yamaguchi H
J Mol Cell Cardiol; 2001 Jan; 33(1):95-107. PubMed ID: 11133226
[TBL] [Abstract][Full Text] [Related]
16. L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism.
Wamhoff BR; Bowles DK; McDonald OG; Sinha S; Somlyo AP; Somlyo AV; Owens GK
Circ Res; 2004 Aug; 95(4):406-14. PubMed ID: 15256479
[TBL] [Abstract][Full Text] [Related]
17. Activation of the smooth muscle-specific telokin gene by thyrotroph embryonic factor (TEF).
Zhou J; Hoggatt AM; Herring BP
J Biol Chem; 2004 Apr; 279(16):15929-37. PubMed ID: 14702338
[TBL] [Abstract][Full Text] [Related]
18. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes.
Yoshida T; Sinha S; Dandré F; Wamhoff BR; Hoofnagle MH; Kremer BE; Wang DZ; Olson EN; Owens GK
Circ Res; 2003 May; 92(8):856-64. PubMed ID: 12663482
[TBL] [Abstract][Full Text] [Related]
19. Purine-rich element binding protein B attenuates the coactivator function of myocardin by a novel molecular mechanism of smooth muscle gene repression.
Ferris LA; Foote AT; Wang SX; Kelm RJ
Mol Cell Biochem; 2021 Aug; 476(8):2899-2916. PubMed ID: 33743134
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β1-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor/myocardin protein.
Wang X; Hu G; Betts C; Harmon EY; Keller RS; Van De Water L; Zhou J
J Biol Chem; 2011 Dec; 286(48):41589-41599. PubMed ID: 21984848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]